loader

tsxv:numi

LATEST ARTICLES
Numinus Wellness Inc. Announces Second Quarter Fiscal 2025 Results
pharmaceutical-investing

Numinus Wellness Inc. Announces Second Quarter Fiscal 2025 Results

Numinus Announces the Music as Medicine Event Series

Numinus Announces the Music as Medicine Event Series

KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th

KCSA Psychedelics Virtual Investor Conference Agenda Announced for April 27th & 28th

Numinus Wellness Inc. Reports Q2 2022 Results

Numinus Wellness Inc. Reports Q2 2022 Results

IIROC Trade Resumption - NUMI

IIROC Trade Resumption - NUMI

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Numinus to Participate in Upcoming Investor Conferences in April 2022

Numinus to Participate in Upcoming Investor Conferences in April 2022

Numinus to Host Q2 2022 Results Conference Call on April 14, 2022

Numinus to Host Q2 2022 Results Conference Call on April 14, 2022

Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPS

Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPS

Numinus to Participate in Maxim's 2022 Virtual Growth Conference on March 28-30, 2022

Numinus to Participate in Maxim's 2022 Virtual Growth Conference on March 28-30, 2022

Numinus Expands Natural Psychedelic Research with New Biosecurity License

Numinus Expands Natural Psychedelic Research with New Biosecurity License

Numinus Adds Ayahuasca & San Pedro to Federal License for Psychedelic Research

Numinus Adds Ayahuasca & San Pedro to Federal License for Psychedelic Research

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES